Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term pa [Pathology]. Found 27 abstracts

no pagination
Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. The Prostate. 2007 May;67(6):582-90.
Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ, Global AT. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. New England Journal of Medicine. 2007 May 31;356(22):2271-81.
Morrow M, Freedman G. A clinical oncology perspective on the use of breast MR. Magnetic Resonance Imaging Clinics of North America. 2007 Aug;14(3):363-78.
Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Journal of Urology. 2006 Feb;175(2):425-31.
Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.[see comment]. Journal of Clinical Oncology. 2006 Sep;24(25):4069-77.
Narra K, Borghaei H, Al-Saleem T, Hoglund M, Smith MR. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research. 2006 Jan;30(1):109-14.
Robb VA, Astrinidis A, Henske EP. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.[erratum appears in Mod Pathol. 2006 Jun;19(6):889]. Modern Pathology. 2006 Jun;19(6):839-46.
Diratzouian H, Freedman GM, Hanlon AL, Eisenberg DF, Anderson PR. Importance of physical examination in the absence of a mammographic abnormality for the detection of early-stage breast cancer. Clinical Breast Cancer. 2005 Oct;6(4):330-3.
Dushkin H, Schilder RJ. Imatinib mesylate and its potential implications for gynecologic cancers. Current treatment options in oncology. 2005 Mar;6(2):115-20.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Anal canal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):510-5.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Colon cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):468-91.
Langer CJ. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clinical lung cancer. 2005 Jan;6(5):314-6, 2005 Mar.
Lopez de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJ. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Research. 2005 May 15;65(10):4162-71.
Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate. 2005 Dec;65(4):331-40.
Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. Changing patterns of bone and brain metastases in patients with colorectal cancer. Clinical Colorectal Cancer. 2005 Jul;5(2):108-13.
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004 Jul 29;23(34):5853-7.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Kramer NM, Horwitz EM, Uzzo RG, Hanlon AL, Hanks GE. Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy. BJU international. 2004 Jul;94(1):59-62.
Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, Cairns P. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clinical Cancer Research. 2004 Jan;10(1, Pt. 1):28-32.
Milling SW, Sai T, Silvers WK, Mintz B. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells. Melanoma Research. 2004 Dec;14(6):555-62.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term pa [Pathology]

pa [Pathology] Female Middle Aged dt [Drug Therapy] Male me [Metabolism] Neoplasm Staging mo [Mortality] Non-US Gov't Research Support th [Therapy] Aged ge [Genetics] Comparative Study di [Diagnosis] sc [Secondary] Adult Antineoplastic Combined Chemotherapy Protocols 80 and over Aged Biological Tumor Markers Antineoplastic Agents Treatment Outcome 0 (Antineoplastic Agents) Neoplasm Invasiveness Survival Analysis rt [Radiotherapy] tu [Therapeutic Use] Human en [Enzymology] Apoptosis ai [Antagonists & Inhibitors] EC 2-7-1 (mTOR protein) Prostatic Neoplasms Biological) 0 (Tumor Markers EC 2-7-1-37 (Protein Kinases) Neoplasm Proteins Neoplasm Metastasis Protein Kinases aa [Analogs & Derivatives] NIH Research Support-Extramural Breast Neoplasms Lung Neoplasms Tumor Cell Line Proportional Hazards Models 0 (Antineoplastic Combined Chemotherapy Protocols) 0 (Proto-Oncogene Proteins c-bcl-2) su [Surgery] Peptide Fragments Risk Assessment 0 (Peptide Fragments) Ovarian Neoplasms Predictive Value of Tests Medical Oncology Combined Modality Therapy Bone Neoplasms bl [Blood] Drug Dose-Response Relationship Squamous Cell Carcinoma Disease Progression 0 (Neoplasm Proteins) st [Standards] ae [Adverse Effects] Sirolimus 1-Phosphatidylinositol 3-Kinase 0 (Proto-Oncogene Proteins) US Gov't Support-PHS Proto-Oncogene Proteins an [Analysis] Adenocarcinoma Feasibility Studies Phosphorylation Prognosis Isoenzymes Enzymologic Gene Expression Regulation ad [Administration & Dosage] Kidney Neoplasms bi [Biosynthesis] Retrospective Studies Brain Neoplasms Colorectal Neoplasms co [Complications] pd [Pharmacology] de [Drug Effects] tu [Therapeutic Use] im [Immunology] Transfection Proto-Oncogene Proteins c-bcl-2 EC 2-7-1-137 (1-Phosphatidylinositol 3-Kinase) 53123-88-9 (Sirolimus) Neoplasm DNA Cytotoxic T-Lymphocytes Vitamin E Neoplasm) 0 (DNA 0 (Neuropeptides) Multivariate Analysis Cisplatin NF-kappa B Inbred F344 Rats Lymphocytic Leukemia-Chronic CD8-Positive T-Lymphocytes Local Neoplasm Recurrence 0 (Melan-A protein) 0 (Chromones) EC 2-7-1 (protein kinase C alpha) ep [Epidemiology] cy [Cytology] Aging 0 (Protein Precursors) Immunohistochemistry Piperazines 0 (Imidazoles) Salvage Therapy Magnetic Resonance Imaging 118072-93-8 (zoledronic acid) Liver Neoplasms Incidence 0 (cci 779) Dinoprostone 951-77-9 (Deoxycytidine) Cell Adhesion Intraductal Carcinoma-Noninfiltrating Cyclin-Dependent Kinase Inhibitor p21 human) 0 (RHEB protein et [Etiology] ras Proteins Secondary Hypertrophic Osteoarthropathy Reverse Transcriptase Polymerase Chain Reaction 0 (Diphosphonates) Imidazoles Monomeric GTP-Binding Proteins 0 (Morpholines) 0 (Immunoglobulin G) Cultured Cells Biological Availability Diphosphonates Experimental Melanoma Neuropeptides EC 1-3-1-2 (Dihydrouracil Dehydrogenase (NADP)) EC 3-6-5-2 (Monomeric GTP-Binding Proteins) Simian virus 40 Colonic Neoplasms Neoplastic Gene Expression Regulation 0 (rituximab) 0 (Isoenzymes) Immunoglobulin G Cell Division Cell Survival ci [Chemically Induced] Thymidine Phosphorylase Monophenol Monooxygenase
Last updated on Wednesday, February 05, 2020